Form D · Other Technology
OSTARA NUTRIENT RECOVERY TECHNOLOGIES INC
Vancouver, A1 · CIK 0001439004
Offering snapshot reported Dec 23, 2019 · SEC filing
- Reported sold
- $4.93M Offering amount: $7.29M
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 17, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 23, 2019 | Initial | $4,930,631 | No comparison | 7 | SEC filing |
| Jan 9, 2019 | Initial | $6,159,393 | No comparison | 14 | SEC filing |
| Aug 8, 2018 | Amendment | $10,342,377 | $3,055,000vs May 9, 2018 | 8 | SEC filing |
| May 9, 2018 | Initial | $7,287,377 | No comparison | 4 | SEC filing |
| Jun 11, 2015 | Initial | $5,749,999 | No comparison | 4 | SEC filing |
| Jan 2, 2014 | Initial | $629,207 | No comparison | 3 | SEC filing |
| Apr 30, 2013 | Initial | $1,983,755 | No comparison | 3 | SEC filing |
| Sep 18, 2012 | Initial | $1,900,002 | No comparison | 3 | SEC filing |
| Sep 4, 2012 | Initial | $1,479,999 | No comparison | 3 | SEC filing |
| Jun 12, 2012 | Initial | $5,070,000 | No comparison | 4 | SEC filing |
| Jan 17, 2012 | Initial | $5,152,682 | No comparison | 14 | SEC filing |
| Jun 27, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-356350
Source: Form D, filed Dec 23, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| F. Phillip Abrary | Director, Executive |
| Thomas Bevilacqua | Director |
| Ahren T. Britton | Executive |
| Josh Cinnamon | Executive |
| Fredric Corrigan | Director, Executive |
| Robert Crystal | Executive |
| Ryan De Berry | Executive |
| Myles Degenstein | Executive |
| J. Stephan Dolezalek | Director |
| Edward Jones | Executive |
| Robert Kennedy | Director |
| Robert F. Kennedy, Jr. | Director |
| Angus Livingstone | Director |
| Scott Mc Donald | Executive |
| Joseph E. Mc Hugh | Director |
| Iyad Omari | Director |
| Dinesh Parmar | Director, Executive |
| Steven Pinney | Director |
| Graham Ramsbottom | Director |
| Rafael Simon | Director |
| Koert Vanden Enden | Executive |
| N/A Vantage Point Capital Partners | Promoter |
| Leonard Zapalowski | Executive |
| Len Zapalowski | Executive |
Issuer details
Industry: Other Technology (See others in industry)
Address:
690 1190 West Pender Street
Vancouver, A1, V6E 2R1
Vancouver, A1, V6E 2R1